FDA hearing on Amgen's Tavneos will include findings from an independent review

12th June 2026 Uncategorised 0

An independent research firm is reviewing data on Amgen’s Tavneos as the company prepares for a hearing with the FDA which could determine whether the rare disease treatment remains on the market.

More: FDA hearing on Amgen's Tavneos will include findings from an independent review
Source: fierce